Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AdvancedDx Biological Laboratories is the U.S. affiliate of ABL Diagnostics, focused on commercializing molecular biology assays, next-generation sequencing workflow products, and analysis software for microbiology laboratories. The company supplies research-use-only sequencing kits, library preparation reagents, and DeepChek software for genotyping, drug-resistance analysis, and microbiology applications. Its portfolio is concentrated in infectious disease and laboratory genomics, including HIV, viral hepatitis, SARS-CoV-2, tuberculosis, HPV, CMV, influenza, and 16S-based microbiology use cases. In addition to product distribution, the company supports logistics, warehousing, biobanking, and clinical-trial sample management in the United States in coordination with affiliated ABL Group capabilities. The business appears to be a commercial-stage diagnostics and lab-solutions organization rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AdvancedDx Biological Laboratories.